SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026

Geneva, Switzerland, November 20, 2026 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage

ADXN

Related stories